-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Silexion Therapeutics Corp quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2023 to Q2 2025.
- Silexion Therapeutics Corp Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 580K shares, a 7687% increase year-over-year.
- Silexion Therapeutics Corp annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 41.6K shares, a 456% increase from 2023.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)